Ixekizumab (Taltz)

What is ixekizumab?

Ixekizumab (Taltz) is an injectable biologic medication used in dermatology for moderate-to-severe plaque psoriasis and psoriatic arthritis. It is part of the IL-17 biologic class and is commonly used for patients who need treatment beyond topical medications or phototherapy.

It is one of the better-known IL-17 biologics and is often compared with other advanced psoriasis treatments when patients want a highly targeted systemic option.

How does ixekizumab work?

Ixekizumab targets interleukin-17A (IL-17A), an inflammatory signal that plays an important role in psoriasis. By blocking this pathway, ixekizumab can help reduce redness, scaling, and plaque thickness.

This is part of why IL-17 agents are often discussed for patients with more active plaque disease who need treatment beyond creams, light therapy, or older oral medications.

What are possible side effects of ixekizumab?

Possible side effects can include:

  • Injection site reactions

  • Upper respiratory symptoms

  • Yeast infections in some patients

  • New or worsening inflammatory bowel disease in a small number of patients

As with other biologic medications, infection screening, vaccination review, and overall treatment risks should be discussed with the prescribing clinician. Gastrointestinal history can also matter when deciding whether an IL-17 medication is the best fit.

How is ixekizumab used?

Ixekizumab is given by injection on a schedule directed by your provider. Some patients may be able to self-inject after training. The medication is stored in the refrigerator.

Because it is an IL-17 biologic, ixekizumab is often compared with other agents in that class when choosing a psoriasis treatment plan. The final choice may depend on joint symptoms, bowel history, prior biologic response, and insurance coverage.

THIS CONTENT IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES AND MAY NOT BE COMPREHENSIVE. IT DOES NOT CONSTITUTE MEDICAL ADVICE. PLEASE REFER TO OUR TERMS OF USE FOR FURTHER DETAILS. ALWAYS CONSULT WITH YOUR HEALTHCARE PROVIDER BEFORE MAKING ANY MEDICAL DECISIONS.